Equity Method Investment (Tables)

12 Months Ended

Dec. 31, 2022

Equity Method Investment

Schedule of financial information of Angel Pharmaceuticals Co.

Summary financial information for Angel Pharmaceuticals is as follows:

		As of		As of
Balance Sheet Data	December 31, 2022		December 31, 2021
	(in thousands)
Current assets	$	29,062	$	38,608
Non-current assets		1,652		1,818
Current liabilities		6,293		2,119
Non-current liabilities		985		105
Stockholders' equity		23,436		38,202

	Year Ended December 31,
Statement of Operations Data	2022		2021		2020 (1)
	(in thousands)
Net loss	$	(11,846)	$	(5,697)	$	(274)
Share of loss from investments accounted for using the equity method		(10,005)		(4,831)		(234)

(1) The Company’s share of loss is based on net loss beginning October 2020 upon the deconsolidation of Angel Pharmaceuticals.